Can hydralazine (apresoline) cause organizing pneumonia or a 'crazy paving' pattern on computed tomography (CT) scans?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Hydralazine and Organizing Pneumonia/Crazy Paving Pattern

While hydralazine is not specifically documented in the provided evidence as causing organizing pneumonia or crazy paving patterns, drug-induced organizing pneumonia is a well-recognized entity that can present with these CT findings, and hydralazine is a known cause of drug-induced lung disease (particularly lupus-related pneumonitis). The absence of hydralazine in the specific drug lists provided does not exclude it as a potential cause, as drug-induced pneumonitis can occur with numerous medications.

Understanding Drug-Related Pneumonitis Patterns

Drug-related pneumonitis (DRP) can manifest with multiple CT patterns, including organizing pneumonia (OP) and crazy paving appearance, and diagnosis relies heavily on temporal relationships between drug administration and symptom onset. 1

Organizing Pneumonia Pattern on CT

The organizing pneumonia pattern demonstrates: 1

  • Multifocal patchy alveolar opacities with peribronchovascular and/or peripheral distribution
  • May demonstrate reversed halo sign
  • Consolidation in peribronchovascular and/or peripheral distribution, often with ground-glass opacity 1

Crazy Paving Pattern

The crazy paving pattern consists of: 1

  • Ground-glass opacity with superimposed interlobular septal thickening and intralobular interstitial thickening
  • This pattern is nonspecific and can result from various diseases including drug-induced pneumonitis 2
  • Originally described in pulmonary alveolar proteinosis but now recognized in multiple conditions 1, 2

Documented Drug Causes of Organizing Pneumonia

The evidence identifies several drug classes that definitively cause organizing pneumonia: 3

  • Salicylates (sulfasalazine, 5-ASA)
  • Methotrexate (causing hypersensitivity pneumonitis or pulmonary fibrosis with organizing features)
  • Anti-TNF monoclonal antibodies (paradoxically causing granulomatous inflammation compatible with organizing pneumonia)
  • Thiopurines (associated with parenchymal lung disease including organizing pneumonia patterns)

Diagnostic Approach for Suspected Drug-Induced Organizing Pneumonia

When evaluating a patient on hydralazine with organizing pneumonia or crazy paving pattern, the key diagnostic steps include: 1

  1. Establish temporal relationship between hydralazine initiation and symptom onset
  2. Exclude infectious etiologies through bronchoscopy with bronchoalveolar lavage (BAL) 4
  3. Exclude other causes including malignancy, connective tissue disease, and other drug exposures 3, 5
  4. Consider surgical lung biopsy if diagnosis remains uncertain after non-invasive testing 4

Critical Pitfall to Avoid

Do not attribute respiratory symptoms solely to opportunistic infection in patients on multiple medications—drug-induced organizing pneumonia must be considered in the differential. 3 The diagnosis of drug-related pneumonitis is based on temporal relationships and exclusion of alternative causes, as CT patterns are typically nonspecific for any particular drug. 1

Management Considerations

If hydralazine-induced organizing pneumonia is suspected: 4, 6

  • Discontinue the offending agent (hydralazine)
  • Initiate oral corticosteroids (typically prednisone ~50 mg/day initially) as the mainstay of treatment
  • Monitor for treatment response with follow-up imaging
  • Watch for relapses, which are common even with appropriate treatment
  • Assess for progression to fibrotic disease, which can occur in a subgroup of patients despite treatment

The prognosis varies significantly: secondary organizing pneumonia (drug-induced) has a 5-year survival rate of 44%, compared to 73% for cryptogenic organizing pneumonia. 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

"Crazy paving appearance" on high resolution CT in various diseases.

Journal of computer assisted tomography, 1999

Guideline

Organizing Pneumonia Causes and Associations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Organizing Pneumonia Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Update on cryptogenic organizing pneumonia.

Frontiers in medicine, 2023

Guideline

Organizing Pneumonia Diagnosis and Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.